Information for "CSL-112 Trial - Phase 2a"
Jump to navigation
Jump to search
Basic information
| Display title | CSL-112 Trial - Phase 2a |
| Redirects to | A Single Ascending Dose Study Examining the Safety and Pharmacokinetic Profile of Reconstituted High Density Lipoprotein (CSL112) Administered to Patients (info) |
| Default sort key | CSL-112 Trial - Phase 2a |
| Page length (in bytes) | 168 |
| Namespace ID | 0 |
| Page ID | 236656 |
| Page content language | en - English |
| Page content model | wikitext |
| Indexing by robots | Allowed |
| Number of redirects to this page | 0 |
| Number of subpages of this page | 0 (0 redirects; 0 non-redirects) |
Page protection
| Edit | Allow all users (infinite) |
| Move | Allow all users (infinite) |
Edit history
| Page creator | Hilda Mahmoudi (talk | contribs) |
| Date of page creation | 14:29, 20 September 2013 |
| Latest editor | Hilda Mahmoudi (talk | contribs) |
| Date of latest edit | 14:29, 20 September 2013 |
| Total number of edits | 1 |
| Total number of distinct authors | 1 |
| Recent number of edits (within past 30 days) | 0 |
| Recent number of distinct authors | 0 |